Average Co-Inventor Count = 5.61
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (6 from 2,078 patents)
2. Tibotec Pharmaceuticals Ltd. (2 from 66 patents)
3. Respivert Limited (1 from 63 patents)
4. Janssen R&d Ireland (45 patents)
9 patents:
1. 12269813 - Crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate
2. 9642799 - Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide
3. 8853406 - Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53
4. 8759519 - Mono-hydrochloric salts of an inhibitor of histone deacetylase
5. 8716282 - Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors
6. 8629144 - Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline
7. 8546428 - Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
8. 8426434 - Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
9. 8143402 - Polymorphic forms of a macrocyclic inhibitor of HCV